Cancer

December 2, 2021

Thyroid cancer paper lands national recognition

By Doug Campbell
December 2, 2021

Reid selected for clinical trial development program

Vanderbilt’s Sonya Reid, MD, MPH, has been selected to participate in the first cohort of the Bristol Myers Squibb Foundation Clinical Trial Diversity Career Development Program.

By Tom Wilemon
November 18, 2021

‘Multi-omics’ reveals treatment option for breast cancer subtype

By Bill Snyder
November 18, 2021

Team receives Association of Community Cancer Centers Innovator Award

A team of Vanderbilt employees have received and award for implementing a streamlined follow-up protocol for patients who may not know they have cancer.

By Tom Wilemon
November 18, 2021

Chic Awearness gala to support ovarian cancer research set for Dec. 6

Chic Awearness, a fashion show and fundraiser for ovarian cancer research, returns as an in-person event from 6:30 p.m. to 8:30 p.m. on Monday, Dec. 6.

By Tom Wilemon
Ayaka Sugiura and Jeff Rathmell, PhD, are studying a metabolic enzyme involved in T cell function that may offer a new target for anti-inflammatory therapeutics.
November 11, 2021

CRISPR screen identifies new anti-inflammatory drug target

A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.

By Leigh MacMillan
November 4, 2021

Koerkenmeier named VICC associate nursing officer

By Tom Wilemon
November 1, 2021

Breast cancer survivors: eat nuts

Breast cancer survivors who reported eating nuts regularly had 50% reduced risk of breast cancer recurrence, metastasis or mortality, Vanderbilt epidemiologists found in Shanghai Breast Cancer Survival Study.
By Leigh MacMillan
October 28, 2021

Reid receives NRG Oncology early-stage investigator award

Vanderbilt's Sonya Reid, MD, MPH, is a recipient of an NRG Oncology Underserved Minority Scholars Award.
By Tom Wilemon
October 28, 2021

V Foundation to support study of pediatric soft tissue sarcoma

By Doug Campbell
October 28, 2021

VICC’s Mayer departing to take new role with AstraZeneca

Ingrid Mayer, MD, MSCI, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca.
By Tom Wilemon
October 21, 2021

New robot enhances accuracy of head, neck cancer surgeries

By Emily Stembridge
October 21, 2021

Study to evaluate how environment impacts cancer risk

Vanderbilt-Ingram Cancer Center is leading an ambitious project to assess the impact of environmental exposures on cancer risk for people living in Southern states.
By Tom Wilemon
1 … 14 15 16 17 18 … 65